Odyssey Therapeutics, Inc. · NASDAQ:ODTX
Nan Li bought 1,111,111 Odyssey Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 11, 2026
On May 11, 2026, Nan Li (Director) bought 1,111,111 Odyssey Therapeutics, Inc. shares at US$18.00 for US$20M, leaving 3,333,516 shares. Filed May 11, 2026 (Form 4).
- Bought
- 1,111,111 shares
- Price
- US$18.00
- Value
- US$20M
- Holding after
- 3,333,516 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Conversion | 1,709,543 | 2,222,405 | Indirect | |
| May 11, 2026 | Common Stock | Buy | 1,111,111 | US$18.00 | 3,333,516 | Indirect |
Source
Related
- Odyssey Therapeutics, Inc.
- Nan Li
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13G · Lightspeed Venture Partners XV-B (Ignite), L.P. · May 18, 2026
- Schedule 13D · Jeito II S.L.P. · May 15, 2026